Volume 14, Issue 2 (6-2026)
J Surg Trauma 2026, 14(2): 58-63 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hakimzadeh F. Comparative Efficacy and Safety of Ketorolac and Ketamine in the Management of Traumatic Chest Pain: A Narrative Review. J Surg Trauma 2026; 14 (2) :58-63
URL: http://jsurgery.bums.ac.ir/article-1-528-en.html
URL: http://jsurgery.bums.ac.ir/article-1-528-en.html
Department of Emergency Medicine, Birjand University of Medical Sciences, Birjand, Iran
Abstract: (722 Views)
Traumatic chest pain, commonly resulting from rib fractures and blunt thoracic trauma, poses a significant analgesic challenge. Ketorolac (a nonsteroidal anti-inflammatory drug) and ketamine (an N-methyl-D-aspartate receptor antagonist) are widely used as opioid-sparing alternatives. This narrative review aimed to synthesize and critically appraise the literature comparing ketorolac and ketamine for pain management in traumatic chest injuries, focusing on efficacy, safety, and clinical applicability. Evidence suggests that ketamine provides faster and superior short-term analgesia, particularly among patients requiring chest tube insertion. At the same time, ketorolac is associated with reduced opioid consumption and lower pulmonary complication rates in rib fracture cohorts. Most findings were derived from indirect comparisons, with only one direct head-to-head randomized controlled trial (RCT) available. Both agents demonstrate favorable safety profiles, though ketamine may cause transient psychedelic effects, and ketorolac may cause bleeding or renal risks in high-risk populations. Given the limited direct comparative data, clinicians may consider ketamine for rapid analgesia and ketorolac for opioid-sparing benefits, tailoring choice to patient-specific factors. Future research should include well-designed RCTs comparing combination versus monotherapy, optimal dosing strategies, and long-term outcomes. Due to the paucity of direct comparative trials, conclusions rely primarily on indirect evidence and a single head-to-head study.
Type of Study: Review |
Subject:
Emergency Medicine
Received: 2025/12/15 | Accepted: 2026/01/31 | ePublished ahead of print: 2026/02/2 | Published: 2026/06/6
Received: 2025/12/15 | Accepted: 2026/01/31 | ePublished ahead of print: 2026/02/2 | Published: 2026/06/6
References
1. 1. Kibu OD, Nguefack-Tsague G, Maqungo S, Ngekeng S, Delon FND, Touko D, et al. Factors associated with mortality in thoracic trauma patients in Cameroon. Heliyon. 2025 Jan 15;11(1). [URL: https://www.cell.com/heliyon] [DOI:10.1016/j.heliyon.2024.e41499] [PMID] [PMCID]
2. Lovisari F, Favarato M, Giovannini I, Giudici R, Fumagalli R. Chest wall pain management after chest wall trauma. JOVS. 2020 Jan 1;6:18.[DOI: 10.21037/jovs.2019.11.01] [DOI:10.21037/jovs.2019.11.01]
3. Lvovschi VE, Carrouel F, Hermann K, Lapostolle F, Joly L-M, Tavolacci M-P. Severe pain management in the emergency department: patient pathway as a new factor associated with IV morphine prescription. fpubh. 2024;12:1352833. [DOI:10.3389/fpubh.2024.1352833] [DOI:10.3389/fpubh.2024.1352833] [PMID] [PMCID]
4. Lindbeck G, Shah MI, Braithwaite S, Powell JR, Panchal AR, Browne LR, et al. Evidence-based guidelines for prehospital pain management: recommendations. PHEM. 2023;27(2):144-53.[DOI:10.1080/10903127.2021.2018073] [DOI:10.1080/10903127.2021.2018073] [PMID]
5. Cohen B, Talmy T, Gelikas S, Radomislensky I, Kontorovich-Chen D, Cohen B, et al. Opioid sparing effect of ketamine in military prehospital pain management-a retrospective study. J. Trauma Acute Care Surg. 2022;93(2S):S71-S7.[DOI:10.1097/TA.0000000000003695] [DOI:10.1097/TA.0000000000003695] [PMID]
6. Mahmoodabadi HZ, Javadein ZS, Moosaie F, Faegh A, Bahreini M. Comparison of the analgesic dose of intravenous ketamine versus ketorolac in patients with chest trauma: A randomized double‐blind clinical trial. AEM 2025;32(4):426-33.[DOI:10.1111/acem.15050] [DOI:10.1111/acem.15050] [PMID] [PMCID]
7. Jett M-F, Ramesha CS, Brown CD, Chiu S, Emmett C, Voronin T, et al. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. JPET . 1999;288(3):1288-97.[DOI:10.1016/S0022-3565(24)38085-1] [DOI:10.1016/S0022-3565(24)38085-1] [PMID]
8. Chen J-Y, Ko T-L, Wen Y-R, Wu S-C, Chou Y-H, Yien H-W, et al. Opioid-sparing effects of ketorolac and its correlation with the recovery of postoperative bowel function in colorectal surgery patients: a prospective randomized double-blinded study. Clin. J Pain. 2009;25(6):485-9. [DOI:10.1097/AJP.0b013e31819a506b] [DOI:10.1097/AJP.0b013e31819a506b] [PMID]
9. Afolabi M, Rodriguez-Silva J, Chopra I, Macias-Perez I, Makii J, Durr E, et al. Real-world evaluation of select adverse drug reactions and healthcare utilization associated with parenteral Ibuprofen and ketorolac in adult and pediatric patients. Front Pain Res. 2025;5:1484948[DOI:10.3389/fpain.2024.1484948] [DOI:10.3389/fpain.2024.1484948] [PMID] [PMCID]
10. Reede K, Bartholomew R, Nielsen D, Ahmeti M, Zreik K, Nielsen DJ. Ketamine in trauma: a literature review and administration guidelines. Cureus. 2023;15(11).[DOI:10.7759/cureus.48099] [DOI:10.7759/cureus.48099] [PMID] [PMCID]
11. Moy R, Wright C. Ketamine for military prehospital analgesia and sedation in combat casualties. BMJ Mil Health. 2018 Nov 1;164(6):436-7.[DOI:10.1136/jramc-2018-000910] [DOI:10.1136/jramc-2018-000910] [PMID]
12. Afify E, Mohamed S, Khedr M. Ketamine: Recent evidence and current uses. BJAS. 2023;8(2):111-7[DOI:10.21608/bjas.2023.208756.1165] [DOI:10.21608/bjas.2023.208756.1165]
13. Bahreini M, Rashnavandi H, Rasooli F, Jalali A, Masoumi R, Mirfazaelian H. Efficacy and adverse effects of lower doses of ketorolac; a systematic review and meta-analysis. Pain Manag. 2025;15(10):733-44. [DOI:10.1080/17581869.2025.2560293] [DOI:10.1080/17581869.2025.2560293] [PMID] [PMCID]
14. Forestell B, Sabbineni M, Sharif S, Chao J, Eltorki M. Comparative effectiveness of ketorolac dosing strategies for emergency department patients with acute pain. Ann Emerg Med. 2023;82(5):615-23. [DOI:10.1016/j.annemergmed.2023.04.011] [DOI:10.1016/j.annemergmed.2023.04.011] [PMID]
15. Li L, Vlisides PE. Ketamine: 50 years of modulating the mind. Front. hum neurosc. 2016;10:612.[DOI:10.3389/fnhum.2016.00612] [DOI:10.3389/fnhum.2016.00612]
16. Kamp J, Van Velzen M, Olofsen E, Boon M, Dahan A, Niesters M. Pharmacokinetic and pharmacodynamic considerations for NMDA-receptor antagonist ketamine in the treatment of chronic neuropathic pain: an update of the most recent literature. Expert Opin Drug Metab Toxicol. 2019;15(12):1033-41[DOI:10.1080/17425255.2019.1689958] [DOI:10.1080/17425255.2019.1689958] [PMID]
17. Gamarra-Sánchez CD, Rodriguez-Silva CN, Cordova-Muñoz A, Asmad-Cruz L, Silva-Correa CR, Villarreal-La Torre VE. In silico design of new ketorolac bioisosteres as anti-inflammatory agents. J Appl Pharm Sci. 2024;14(4):155-62.[DOI:10.7324/JAPS.2024.162337] [DOI:10.7324/JAPS.2024.162337]
18. Vines L, Sotelo D, Johnson A, Dennis E, Manza P, Volkow ND, et al. Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions. Intell Med. 2022 May 28;2(02):61-8.[URL: www.elsevier.com/locate/imed] [DOI:10.1016/j.imed.2022.03.001] [PMID] [PMCID]
19. Beiter JL, Simon HK, Chambliss CR, Adamkiewicz T, Sullivan K. Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness. Arch Pediatr Adolesc Med. 2001;155(4):496-500. [DOI:10.1001/archpedi.155.4.496] [DOI:10.1001/archpedi.155.4.496] [PMID]
20. Dong TT, Mellin-Olsen J, Gelb AW. Ketamine: a growing global health-care need. BJA. 2015 Oct 1;115(4):491-3.[DOI:10.1093/bja/aev215] [DOI:10.1093/bja/aev215] [PMID]
21. Howard ML, Warhurst RD, Sheehan C. Safety of continuous infusion ketorolac in postoperative coronary artery bypass graft surgery patients. Pharmacy. 2016;4(3):22.[DOI:10.3390/pharmacy4030022] [DOI:10.3390/pharmacy4030022] [PMID] [PMCID]
22. Shimonovich S, Gigi R, Shapira A, Sarig-Meth T, Nadav D, Rozenek M, et al. Intranasal ketamine for acute traumatic pain in the Emergency Department: a prospective, randomized clinical trial of efficacy and safety. BMC Emerg Med.. 2016;16(1):43.[DOI:10.1186/s12873-016-0107-0] [DOI:10.1186/s12873-016-0107-0] [PMID] [PMCID]
23. Kugler NW, Carver TW, Juul J, Peppard WJ, Boyle K, Drescher KM, et al. Ketamine infusion for pain control in elderly patients with multiple rib fractures: results of a randomized controlled trial. J Trauma Acute Care Surg. 2019;87(5):1181-8.[DOI:10.1186/s12873-016-0107-0] [DOI:10.1186/s12873-016-0107-0] [PMID] [PMCID]
24. Shehata MM, Reinert JP. The Efficacy and Safety of Ketamine or Ketorolac Compared to Opioids in Painful Vaso-Occlusive Crisis: A Systematic Review and Meta-Analysis. Ann. Pharmacother.10600280251380939. [DOI:10.1177/10600280251380939] [DOI:10.1177/10600280251380939] [PMID]
25. Mudhaya RA, Alhakami RA, Alsulami WF, Aladwani MI, Alsamti AM, Almutairi AO, et al. Pain Management Interventions in Military Medicine: State-of-the-Art Pain Management Modalities Used by Physicians and Nurses in Ministry of Defense Hospitals for Trauma Incurred During Combat. J Med Life Sci. 2025;7(4):659-70.[DOI:10.21608/jmals.2025.454697] [DOI:10.21608/jmals.2025.454697]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Attribution-NoneCommercial CC BY-NC
